SNSE Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sensei Biotherapeutics Inc (SNSE).


$12.33M Market Cap.

As of 03/28/2025 5:00 PM ET (MRY) • Disclaimer

SNSE Market Cap. (MRY)


SNSE Shares Outstanding (MRY)


SNSE Assets (MRY)


Total Assets

$45.36M

Total Liabilities

$6.97M

Total Investments

$31.34M

SNSE Income (MRY)


Revenue

$0

Net Income

-$30.16M

Operating Expense

$32.61M

SNSE Cash Flow (MRY)


CF Operations

-$24.67M

CF Investing

$22.44M

CF Financing

-$787.00K

SNSE Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

SNSE Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$45,361,000 (-39.01%)

$74,374,000 (-37.17%)

$118,375,000 (-22.74%)

$153,225,000 (615.07%)

Assets Current

$41,929,000 (-37.65%)

$67,250,000 (-38.07%)

$108,589,000 (-26.90%)

$148,542,000 (639.90%)

Assets Non-Current

$3,432,000 (-51.82%)

$7,124,000 (-27.20%)

$9,786,000 (108.97%)

$4,683,000 (246.38%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$38,386,000 (-40.85%)

$64,895,000 (-37.24%)

$103,407,000 (-29.42%)

$146,513,000 (359.58%)

Property Plant & Equipment Net

$3,384,000 (-51.92%)

$7,038,000 (-27.61%)

$9,723,000 (109.37%)

$4,644,000 (266.82%)

Cash & Equivalents

$9,994,000 (-23.19%)

$13,011,000 (-26.88%)

$17,795,000 (148.57%)

$7,159,000 (-56.86%)

Accumulated Other Comprehensive Income

-$13,000 (93.78%)

-$209,000 (79.18%)

-$1,004,000 (-201.50%)

-$333,000 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$31,341,000 (-40.58%)

$52,746,000 (-40.95%)

$89,321,000 (-36.41%)

$140,462,000 (0%)

Investments Current

$31,341,000 (-40.58%)

$52,746,000 (-40.95%)

$89,321,000 (-36.41%)

$140,462,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,248,000 (-26.33%)

$1,694,000 (-62.13%)

$4,473,000 (82.13%)

$2,456,000 (-36.73%)

Accumulated Retained Earnings (Deficit)

-$262,052,000 (-13.00%)

-$231,895,000 (-17.24%)

-$197,794,000 (-32.56%)

-$149,206,000 (-32.73%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,845,000 (-38.06%)

$6,208,000 (-22.72%)

$8,033,000 (241.25%)

$2,354,000 (243.65%)

Debt Current

$2,318,000 (-4.96%)

$2,439,000 (14.45%)

$2,131,000 (213.38%)

$680,000 (2025.00%)

Debt Non-Current

$1,527,000 (-59.49%)

$3,769,000 (-36.14%)

$5,902,000 (252.57%)

$1,674,000 (156.36%)

Total Liabilities

$6,975,000 (-26.42%)

$9,479,000 (-36.67%)

$14,968,000 (123.00%)

$6,712,000 (21.26%)

Liabilities Current

$5,448,000 (-3.46%)

$5,643,000 (-37.76%)

$9,066,000 (85.44%)

$4,889,000 (1.22%)

Liabilities Non-Current

$1,527,000 (-60.19%)

$3,836,000 (-35.01%)

$5,902,000 (223.75%)

$1,823,000 (158.58%)

SNSE Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$13,036,000 (-30.53%)

$18,765,000 (-5.25%)

$19,805,000 (25.19%)

$15,820,000 (110.15%)

Research & Development Expense

$18,627,000 (1.79%)

$18,299,000 (-39.77%)

$30,383,000 (40.26%)

$21,662,000 (93.67%)

Operating Expenses

$32,614,000 (-12.01%)

$37,064,000 (-26.15%)

$50,188,000 (33.90%)

$37,482,000 (92.70%)

Interest Expense

$90,000 (-37.50%)

$144,000 (-34.25%)

$219,000 (-67.31%)

$670,000 (-60.33%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$30,157,000 (11.57%)

-$34,101,000 (29.82%)

-$48,588,000 (-32.05%)

-$36,794,000 (-83.05%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$30,157,000 (11.57%)

-$34,101,000 (29.82%)

-$48,588,000 (-32.05%)

-$36,794,000 (-83.05%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$30,157,000 (11.57%)

-$34,101,000 (29.82%)

-$48,588,000 (-32.05%)

-$36,794,000 (-82.11%)

Weighted Average Shares

$25,117,238 (-10.14%)

$27,952,857 (-8.96%)

$30,703,295 (10.80%)

$27,710,686 (1618.88%)

Weighted Average Shares Diluted

$25,117,238 (-10.14%)

$27,952,857 (-8.96%)

$30,703,295 (10.80%)

$27,710,686 (1618.88%)

Earning Before Interest & Taxes (EBIT)

-$30,067,000 (11.46%)

-$33,957,000 (29.80%)

-$48,369,000 (-33.90%)

-$36,124,000 (-96.21%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$32,614,000 (12.01%)

-$37,064,000 (26.15%)

-$50,188,000 (-33.90%)

-$37,482,000 (-92.70%)

SNSE Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$22,440,000 (-41.58%)

$38,412,000 (-23.10%)

$49,949,000 (134.90%)

-$143,118,000 (-10100.86%)

Net Cash Flow from Financing

-$787,000 (92.96%)

-$11,173,000 (-3793.03%)

-$287,000 (-100.18%)

$163,940,000 (362.42%)

Net Cash Flow from Operations

-$24,670,000 (22.96%)

-$32,023,000 (17.94%)

-$39,026,000 (-28.97%)

-$30,259,000 (-70.91%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,017,000 (36.94%)

-$4,784,000 (-144.98%)

$10,636,000 (212.71%)

-$9,437,000 (-157.74%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$22,586,000 (-41.22%)

$38,426,000 (-23.54%)

$50,255,000 (135.54%)

-$141,410,000 (0%)

Capital Expenditure

-$146,000 (-942.86%)

-$14,000 (95.42%)

-$306,000 (82.08%)

-$1,708,000 (-41.63%)

Issuance (Repayment) of Debt Securities

-$811,000 (-6.57%)

-$761,000 (-20.99%)

-$629,000 (-146.67%)

-$255,000 (-148.48%)

Issuance (Purchase) of Equity Shares

$24,000 (100.23%)

-$10,412,000 (-3144.44%)

$342,000 (-99.76%)

$140,703,000 (703415.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$3,135,000 (-29.61%)

$4,454,000 (-23.37%)

$5,812,000 (2.74%)

$5,657,000 (279.16%)

Depreciation Amortization & Accretion

$2,876,000 (6.20%)

$2,708,000 (6.57%)

$2,541,000 (270.95%)

$685,000 (227.75%)

SNSE Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-61.90% (-40.68%)

-44.00% (-8.37%)

-40.60% (-75.76%)

-23.10% (-171.52%)

Return on Average Assets (ROAA)

-53.60% (-38.86%)

-38.60% (-6.34%)

-36.30% (-62.05%)

-22.40% (87.44%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-70.20% (-62.12%)

-43.30% (-9.90%)

-39.40% (-20.49%)

-32.70% (-103.95%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.41 (28.04%)

-0.57 (39.87%)

-0.94 (78.38%)

-4.36

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.32 (20.22%)

0.27 (-39.73%)

0.44 (-63.42%)

1.21

Debt to Equity Ratio (D/E)

0.18 (24.66%)

0.15 (0.69%)

0.14 (215.22%)

0.05 (146.94%)

Earnings Per Share (EPS)

-1.2 (1.64%)

-1.22 (22.78%)

-1.58 (-18.80%)

-1.33 (89.39%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.99 (13.79%)

-1.15 (10.54%)

-1.28 (-11.01%)

-1.15 (90.16%)

Book Value Per Share (BVPS)

1.53 (-34.19%)

2.32 (-31.06%)

3.37 (-36.30%)

5.29 (115.10%)

Tangible Assets Book Value Per Share (TABVPS)

1.81 (-32.13%)

2.66 (-30.97%)

3.85 (-30.28%)

5.53 (-58.40%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (80.00%)

-5

Enterprise Value Over EBITDA (EV/EBITDA)

0.09 (121.13%)

-0.41 (56.33%)

-0.93 (80.33%)

-4.74

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

7.7 (-35.42%)

11.92 (-0.51%)

11.98 (-60.58%)

30.38 (630.89%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$24,816,000 (22.54%)

-$32,037,000 (18.55%)

-$39,332,000 (-23.04%)

-$31,967,000 (-69.04%)

Enterprise Value (EV)

-$2,336,309 (-118.36%)

$12,725,590 (-70.21%)

$42,721,234 (-74.56%)

$167,901,602

Earnings Before Tax (EBT)

-$30,157,000 (11.57%)

-$34,101,000 (29.82%)

-$48,588,000 (-32.05%)

-$36,794,000 (-83.05%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$27,191,000 (12.99%)

-$31,249,000 (31.81%)

-$45,828,000 (-29.32%)

-$35,439,000 (-94.70%)

Invested Capital

$33,764,000 (-45.48%)

$61,928,000 (-37.79%)

$99,547,000 (-30.64%)

$143,531,000 (20792.43%)

Working Capital

$36,481,000 (-40.78%)

$61,607,000 (-38.10%)

$99,523,000 (-30.72%)

$143,653,000 (842.23%)

Tangible Asset Value

$45,361,000 (-39.01%)

$74,374,000 (-37.17%)

$118,375,000 (-22.74%)

$153,225,000 (615.07%)

Market Capitalization

$12,326,691 (-28.74%)

$17,297,590 (-62.21%)

$45,773,234 (-74.21%)

$177,461,602

Average Equity

$48,707,750 (-37.14%)

$77,486,500 (-35.24%)

$119,654,250 (-24.76%)

$159,024,500 (354.23%)

Average Assets

$56,277,250 (-36.33%)

$88,386,250 (-33.95%)

$133,813,000 (-18.49%)

$164,168,500 (1349.93%)

Invested Capital Average

$42,826,250 (-45.45%)

$78,510,000 (-36.04%)

$122,742,000 (11.12%)

$110,459,750 (5061.14%)

Shares

25,151,379 (0.62%)

24,996,517 (-18.63%)

30,720,291 (0.40%)

30,596,828 (7.57%)